Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Mar;182(3):446-453.
doi: 10.1002/ajmg.a.61462. Epub 2019 Dec 26.

Growth charts in Kabuki syndrome 1

Affiliations

Growth charts in Kabuki syndrome 1

Valentin Ruault et al. Am J Med Genet A. 2020 Mar.

Abstract

Kabuki syndrome (KS, KS1: OMIM 147920 and KS2: OMIM 300867) is caused by pathogenic variations in KMT2D or KDM6A. KS is characterized by multiple congenital anomalies and neurodevelopmental disorders. Growth restriction is frequently reported. Here we aimed to create specific growth charts for individuals with KS1, identify parameters used for size prognosis and investigate the impact of growth hormone therapy on adult height. Growth parameters and parental size were obtained for 95 KS1 individuals (41 females). Growth charts for height, weight, body mass index (BMI) and occipitofrontal circumference were generated in standard deviation values for the first time in KS1. Statural growth of KS1 individuals was compared to parental target size. According to the charts, height, weight, BMI, and occipitofrontal circumference were lower for KS1 individuals than the normative French population. For males and females, the mean growth of KS1 individuals was -2 and -1.8 SD of their parental target size, respectively. Growth hormone therapy did not increase size beyond the predicted size. This study, from the largest cohort available, proposes growth charts for widespread use in the management of KS1, especially for size prognosis and screening of other diseases responsible for growth impairment beyond a calculated specific target size.

Keywords: Kabuki syndrome; growth; growth hormone deficiency; parental target size; specific curves.

PubMed Disclaimer

References

REFERENCES

    1. Armstrong, L., El Moneim, A. A., Aleck, K., Aughton, D. J., Baumann, C., Braddock, S. R., … Allanson, J. E. (2004). Further delineation of Kabuki syndrome in 48 well-defined new individuals. American Journal of Medical Genetics. Part A, 132A(3), 265-272.
    1. Bögershausen, N., & Wollnik, B. (2013). Unmasking Kabuki syndrome. Clinical Genetics, 83(3), 201-211.
    1. Chu, D.-C., Finley, S. C., Young, D. W., & Proud, V. K. (1997). CNS malformation in a child with Kabuki (Niikawa-Kuroki) syndrome: Report and review. American Journal of Medical Genetics, 72(2), 205-209.
    1. Deheeger, M., & Rolland-Cachera, M. F. (2004). Longitudinal study of anthropometric measurements in Parisian children aged ten months to 18 years. Archives of Pediatrics, 11(9), 1139-1144.
    1. de Onis, M. (2007). Development of a WHO growth reference for school-aged children and adolescents. Bulletin of the World Health Organization, 85(09), 660-667.

Publication types

MeSH terms

Supplementary concepts